GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » Interest Expense

Jiangxi Fushine Pharmaceutical Co (SZSE:300497) Interest Expense : ¥-40 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Jiangxi Fushine Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Jiangxi Fushine Pharmaceutical Co's interest expense for the three months ended in Mar. 2025 was ¥ -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-40 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Jiangxi Fushine Pharmaceutical Co's Operating Income for the three months ended in Mar. 2025 was ¥ 18 Mil. Jiangxi Fushine Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -10 Mil. Jiangxi Fushine Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2025 was 1.78. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jiangxi Fushine Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Jiangxi Fushine Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Fushine Pharmaceutical Co Interest Expense Chart

Jiangxi Fushine Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.74 -24.92 -41.10 -42.03 -40.58

Jiangxi Fushine Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.81 -9.93 -9.85 -9.99 -10.42

Jiangxi Fushine Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Fushine Pharmaceutical Co  (SZSE:300497) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jiangxi Fushine Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2025 was ¥-10 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥18 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥631 Mil.

Jiangxi Fushine Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*18.497/-10.418
=1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Jiangxi Fushine Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » Interest Expense
Comparable Companies
SHSE:688075 BJSE:839273 SHSE:603566 SHSE:688293 BJSE:430047 SHSE:688488 SHSE:688046 SHSE:688197 BJSE:833575 SZSE:300318 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.2 YULI Industrial Zone, Changjiang district, Jiangxi Province, Jingdezhen, CHN, 333000
Website
http://www.fushine.cn
Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.
Executives
Liu Ying Executives
Peng Yun Secretary Dong
Zhang Xiang Ming Executives
Wei Hai Peng Executives
Bao Jian Hua Directors, executives
Li Hui Yue Director
Dai Zhen Liang Executives
Yang Guang Executives
Chen Ying Hui Executives
Ke Dan Director
Xu Chun Xia Directors, executives
Yu Wen Jun Director
Cheng Rong Wu Directors, executives
Liu Zhi Min Executives
Tang De Ping Executives

Jiangxi Fushine Pharmaceutical Co Headlines

No Headlines